Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Paclitaxel albumin bound by Bristol-Myers Squibb for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval
Paclitaxel albumin bound is under clinical development by Bristol-Myers Squibb and currently in Phase I for Pancreatic Ductal Adenocarcinoma. According...
Data Insights
Paclitaxel albumin bound by Bristol-Myers Squibb for Metastatic Transitional (Urothelial) Tract Cancer: Likelihood of Approval
Paclitaxel albumin bound is under clinical development by Bristol-Myers Squibb and currently in Phase II for Metastatic Transitional (Urothelial) Tract...